Metabolism of sameridine to monocarboxylated products by hepatocytes isolated from the male rat

Drug Metabolism and Disposition

Volumn 28, Issue 6, 2000, Pages 695-700

  Sohlenius Sternbeck, Anna Karin ^a   Von Euler Chelpin, Hans ^a   Orzechowski, Achim ^a   Halldin, Magnus M ^a  

^a ASTRAZENECA R AND D   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

4 METHYLPYRAZOLE; CYTOCHROME P450 ISOENZYME; LOCAL ANESTHETIC AGENT; PIPERIDINE DERIVATIVE; PROADIFEN; SAMERIDINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG METABOLISM; ENZYME MECHANISM; FATTY ACID OXIDATION; LIVER CELL; LIVER MICROSOME; LOCAL ANESTHESIA; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANESTHETICS, LOCAL; ANIMALS; ANTICHOLESTEREMIC AGENTS; CLOFIBRATE; CYTOCHROME P-450 ENZYME SYSTEM; ENZYME INHIBITORS; LIVER; MALE; PEROXISOMES; PIPERIDINES; PROADIFEN; PYRAZOLES; RATS; RATS, SPRAGUE-DAWLEY;

ANIMALIA;

EID: 0034129835     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Bissell DM and Guzelian PS (1980) Phenotypic stability of adult rat hepatocytes in primary monolayer culture. Ann NY Acad Sci 349:85-98.
2. Bronfman M, Inestrosa NC, Nervi FO and Leighton F (1984) Acyl-CoA synthetase and the peroxisomal enzymes of β-oxidation in human liver. Biochem J 224:709-720.
3. Cai Y, Nelson BD, Li R, Luciakova K and DePierre JW (1996) Thyromimetic action of the peroxisome proliferators clofibrate, perfluorooctanoic acid, and acetylsalicylic acid includes changes in mRNA levels for certain genes involved in mitochondrial biogenesis. Arch Biochem Biophys 325:107-112.
4. Christensen E, Gronn M, Hagve T-A and Christophersen BO (1991) Omega-oxidation of fatty acids studied in isolated liver cells. Biochem Biophys Acta 1081:167-173.
5. Elofsson S, Svensson M, Besidski Y and Lindgren J-E (1996) In vivo metabolism of sameridine in animals and man (Abstract). Presented at the Annual Congress of the Swedish Pharmaceutical Society, Nov. 1996, Stockholm, p. 83.
6. Gatt S, Bremer J and Osmundsen H (1988) Pyrene dodecanoic acid coenzyme A ester: Peroxisomal oxidation and chain shortening. Biochim Biophys Acta 958:130-133.
7. Gibson G (1989) Comparative aspects of the mammalian cytochrome P450IV gene family. Xenobiotica 19:1123-1148.
8. Hardwick JP (1991) CYP4A subfamily: Functional analysis by immunohistochemistry and in situ hybridization. Methods Enzymol 206:273-283.
9. Harvey DJ (1989) Further studies on the oxidative cleavage of the pentyl side-chain of cannabinoids: Identification of a new biotransformation pathway in the metabolism of 3′-hydroxy-delta-9-tetrahydrocannabinol by the mouse. Xenobiotica 19:1437-1447.
10. Harvey DJ (1990) Oxidative cleavage of the pentyl side-chain of cannabinoids. Drag Metab Dispos 18:350-355.
11. 6-tetrahydrocannabinol in the mouse. Drug Metab Dispos 13:215-219.
12. Hyrb DJ and Hogg JM (1979) Chain length specificities of peroxisomal and milochondrial β-oxidation in rat liver. Biochem Biophys Res Commun 87:1200-1206.
13. Kimura S, Hardwick JP, Kozak CA and Gonzalez FJ (1989) The rat clofibrate-mducible CYP4A subfamily. II. cDNA sequence of IVA3, mapping of the Cyp4a locus to mouse chromosome 4, and coordinate and tissue-specific regulation of the CYP4A genes. DNA 8:517-525.
14. Lazarow PB and deDuve C (1976) A fatty acyl-CoA oxidizing system in rat liver peroxisomes: Enhancement by clofibrate, a hypolipidemic drug. Proc Natl Acad Sci USA 73:2043-2046.
15. Lowry OH, Rosebrough NJ, Farr AL and Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275.
16. Orton TC and Parker GL (1982) The effect of hypolipidemic agents on the hepatic microsomal drug-metabolizing enzyme system of the rat. Drug Metab Dispos 10:110-115.
17. Osmundsen H, Bremer J and Pedersen JI (1991) Metabolic aspects of peroxisomal β-oxidation. Biochim Biophys Acta 1085:141-158.
18. Samara E, Bialer M, Bar-On H and Harvey DJ (1990) Identification of metabolites of the 1″,1″-dimethylheptyl analogue of cannabidiol in rat and dog in vivo. Xenobiotica 20:447-455.
19. Schepers L, Van Veldhoven PP, Casteels M, Eyssen HJ and Mannaerts GP (1990) Presence of three acyl-CoA oxidases in rat liver peroxisomes. J Biol Chem 265:5242-5246.
20. Sharma R, Lake BG and Gibson GG (1988) Co-induction of microsomal cytochrome P-452 and the peroxisomal fatty acid symbol 98 β-oxidation pathway in the rat by clofibrate and di-(2-ethylhexyl)phthalate. Biochem Pharmacol 37:1203-1206.
21. Shore JD and Gilleland MJ (1970) Binding and kinetic studies of liver alcohol dehydrogenase-coenzyme-pyrazole complexes. J Biol Chem 245:3422-3425
22. Singh H and Poulos A (1988) Distinct long chain and very long chain fatty acyl-CoA synthetase in rat liver peroxisomes and microsomes. Arch Biochem Biophys 266:486-495.
23. Sinz MW, Black AE, Bjorge SM, Holmes A, Trivedi BK and Woolf TF (1997) In vitro and in vivo disposition of 2.2-dimetyl-n-(2,4,6-trimethoxyphenyl)dodecanamide (C1-976). Drug Metab Dispos 25:123-130.
24. Sundseth SS and Waxman DJ (1992) Sex-dependent expression of clofibrate inducibility of cytochrome P450 4A fatty acid ω-hydroxylases. J Biol Chem 267:3915-3921.
25. Theorell E, Yonetani T and Sjöberg B (1969) On the effects of heterocyclic compounds on the enzymatic activity of liver alcohol dehydrogcnase. Acta Chem Scand 23:255-260.
26. Vamecq J, deHoffman E and VanHoof F (1985) The microsomal dicarboxylyl-CoA synthetase. Biochem J 230:683-693.
27. Vamecq J and Draye J-P (1987) Interactions between the ω-and the β-oxidations of fatty acids. J Biochem 102:225-234.
28. Van Veldhoven PP, Vanhove G, Asselberghs S, Eyssen HJ and Mannaerts GP (1992) Substrate specificities of rat liver peroxisomal acyl-CoA oxidases: Palmitoyl-CoA oxidase (inducible acyl-CoA oxidase), pristanoyl-CoA oxidase (non-inducible acyl-CoA oxidase), and trihydroxycoprostanoyl-CoA oxidase. J Biol Chem 267:20065-20074.
29. Westman L, Valentin A, Eriksson E and Ekblom A (1998) Intrathecal administration of sameridine to patients subjected to arthroscopic knee joint surgery. Acta Anaesthesiol Scand 42:691-697.
30. Yamada J, Horie S, Watanabe T and Suga T (1984) Participation of peroxisomal β-oxidation system in the chain-shortening of a xenobiotic acyl compound. Biochem Biophys Res Commun 125:123-128.
31. Yamada J, Itoh S, Horie S, Watanabe T and Suga T (1986) Chain-shortening of a xenobiotic acyl compound by the peroxisomal β-oxidation system in rat liver. Biochem Pharmacol 35:4363-4368.
32. Yamada J, Ogawa S, Horie S, Watanabe T and Suga T (1987) Participation of peroxisomes in the metabolism of xenobiotic acyl compounds: Comparison between peroxisomal and mitochondrial β-oxidation of ω-phenyl fatty acids in rat liver. Biochim Biophys Acta 921:292-301.